A
|
ADS |
Analytical Decision Support |
AIG |
Anthrax Immune Globulin |
AMCG |
Office of Acquisition Management, Contracts, & Grants |
AMIC |
Animal Model Interagency Committee |
Arenavirus |
The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted diseases in humans. Each virus usually is associated with a particular rodent host species in which it is maintained. |
Animal Efficacy Rule |
The FDA Animal Efficacy Rule (also known as Animal Rule) applies to development/testing of drugs / biologicals to reduce or prevent serious/life-threatening conditions caused by exposure to lethal /permanently disabling toxic agent (chemical, biological, radiological, or nuclear substances), where human efficacy trials are not feasible or ethical |
ARS |
Acute Radiation Syndrome; also known as radiation poisoning, radiation sickness or radiation toxicity, is a collection of health effects which present within 24 hours of exposure to high amounts of ionizing radiation. |
ASPR |
Assistant Secretary for Preparedness and Response |
B
|
BAA |
Broad Agency Announcements |
BARDA |
Biomedical Advanced Research and Development Authority |
BPN |
Business Partner Network |
BSA |
Broad Spectrum Antimicrobials |
C
|
CAP |
Concept Acceleration Program |
CBMS |
Chemical Biological Medical Systems |
CBRN |
Chemical, Biological, Radiological and Nuclear Threats |
CBRND |
Chemical, Biological, Radiological and Nuclear Threats Defense |
CDC |
Center for Desease Control |
CDER |
Center for Drug Evaluation and Research |
CFR |
Code of Federal Regulations |
CIADM |
Centers for Innovation in Advanced Development and Manufacturing |
CLIA |
Clinical Laboratory Improvement Amendment |
CSN |
Clinical Studies Network |
D
|
DARPA |
Defense Advanced Research Projects Agency |
DCEG |
Division of Cancer Epidemiology and Genetics |
DCS |
Clinical Studies group |
DHS |
Department of Homeland Security |
DoD |
Department of Defense |
DSMB |
Data Safety Monitoring Board |
DTRA |
Defense Threat Reduction Agency |
E
|
EID |
Emerging Infectious Diseases |
EMS |
Emergency Medical Services |
EUA |
Emergency Use Authorization |
F
|
FAR |
Federal Acquisition Regulations |
FD&C |
Federal Food, Drug and Cosmetic Act |
FDA |
Food and Drug Administration |
FedBizOpps |
Federal Business Opportunities |
FFMN |
Fill Finish Manufacturing Network |
G
|
GI |
Gastrointestinal |
GPE |
Government Point-of-Entry |
Back to top
H
|
HGS |
Human Genome Sciences |
HHS |
U.S. Department of Health and Human Services |
HHSAR |
Department of Health and Human Services Acquisition Regulation |
I
|
IEDB |
Immune Epitope Database |
IND |
Investigational New Drug |
J
|
JOFOC |
Justification for Other than Full and Open Competition |
M
|
MCM |
Medical Countermeasures |
MCMi |
Medical Countermeasures initiative |
MMWR |
Morbidity and Mortality Weekly Report |
N
|
NARA |
National Archives and Records Administration |
NBLs |
National Biocontainment Laboratories |
NCI |
National Cancer Institute |
NHLBI |
National Heart, Lung and Blood Institute |
NIAID |
National Institute of Allergy and Infectious Diseases |
NIH |
National Institutes of Health |
NINDS |
National Institute of Neurological Disorders and Stroke |
NSABB |
National Science Advisory Board for BioSecurity |
Back to top
O
|
OEM |
Office of Emergency Management |
OMB |
Office of Management and Budget |
OPP |
Office of Policy and Planning |
P
|
PAHPA |
The Pandemic and All Hazards Preparedness Act |
PBS |
Project BioShield |
PDTs |
Product Development Tools |
PEP |
Post-Event Prophylactic |
PHCM |
Public Health Consequence Modeling |
PHEMCE |
Public Health Emergency Medical Countermeasures Enterprise |
PHS |
Public Health Service |
R
|
RBLs |
Regional Biocontainment Laboratories |
RCE |
Regional Centers of Excellence |
REB |
Radiation Epidemiology Branch |
RFP |
Request for Proposal |
RQA |
Division of Regulatory and Quality Affairs |
RSV |
Respiratory Syncytial Virus |
RTOR |
Request for Task Order Response |
S
|
SAE |
Serious Adverse Event |
SIP |
Strategy and Implementation Plan |
SNS |
Strategic National Stockpile |
SST |
Strategic Science and Technology |
T
|
TICs |
Toxic Industrial Chemicals |
TIMs |
Toxic Industrial Materials |
TMTI |
Transformational Medical Technologies Initiative |
TRA |
Terrorism Risk Assessment |
TRLs |
Technology Readiness Levels |